Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/16/22 → 05/18/24 |
Funding
- Novartis Pharmaceuticals Corporation: $71,805.00
Covid-19 Clinical Research: A Randomized, Multicenter, Open-Label Trial Comparing the Effectiveness of an "Inclisiran First" Implementation Strategy to Usual Care on LDL Cholesterol (LDL-C) in Patients with Atheresclerotic Cardiovascular
- Chen, On (PI)
- Lawson, William (CoPI)
- Rahman, Tahmid (CoPI)
- Skopicki, Hal A (CoPI)
- Bloom, Michelle (CoPI)
Project: Research